Navigation
banner

All posts by GTCbio

2017

Where do we stand with cell therapy in diabetes?

GTCbio | February 24th, 2017

Diabetes results from the dysfunction and/or destruction of the insulin producing beta cells in the pancreatic islet. Replacement of beta cells by using progenitor or differentiated stem cells is a promising strategy to treat diabetes.